4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0001193125-25-230511
Options or other derivatives
- Chief Executive Officer acquired 49,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Kulkarni Samarth Chief Executive Officer | 2025-10-03 | Grant or award · Stock Option (Right to Buy) | +49,500 | 49,500 | D | ||
Loading xslF345X05/ownership.xml…